Leisure Capital Management’s Aerie Pharmaceuticals AERI Stock Holding History
Bought
Maintained
Sold
Other funds holding AERI
DM
FCMI
WRF
FCMI
CCM
Leisure Capital Management's AERI Position: Q2 2019 in Review
Leisure Capital Management sold out of Aerie Pharmaceuticals (AERI) in Q2 2019, closing a stake of 8,558 shares — an estimated $407K sold.
Leisure Capital Management first reported a position in AERI in Q2 2015 and held it in 16 quarters. The position peaked at $1.03M in Q4 2017. 167 funds tracked by Wall St. Rank hold AERI as of Q2 2019.
- Leisure Capital Management reported no remaining Aerie Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
- Leisure Capital Management sold 8,558 Aerie Pharmaceuticals shares in Q2 2019, an estimated $407K.
- Leisure Capital Management first reported a position in Aerie Pharmaceuticals in Q2 2015 and held it in 16 quarters.
- Leisure Capital Management's Aerie Pharmaceuticals position peaked at $1.03M in Q4 2017.
- 167 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q2 2019.
Based on Leisure Capital Management's 13F filing for Q2 2019, filed 10 Jul 2019.